According to this article, the number of families who are homeless has gone up 1.4 percent over the last year even though the total number of homeless has gone down. To read more, CLICK HERE.
Here’s a great article addressing why Americans, who were known for constantly changing their address, are now keeping still. To read the article, CLICK HERE.
Have you thought about investing in real estate? Just don’t know if you should? Here’s a great article that offers reasons on why you should be investing. To read more, CLICK HERE.
I’m sure you’ve heard of a home bidding war. But have you ever heard of one where the opposing buyer offers you $10,000 to walk away? The housing market in Texas has definitely hit a growth spurt. To read more, CLICK HERE.
Buying a home can be exhausting and stressful. But there are some things you may want to consider before buying. This may seem obvious but always look for a home you can truly afford. Use an online calculator to factor in your income and debts. To read more, CLICK HERE.
Let’s say your budget for buying a new home is $400,000, what kind of a house can you purchase? What might be considered an “inexpensive” home in one region might be a mansion in another. For example, in Overland Park, Kan. you can purchase a 4,298 square foot home, however, in Ashland, Ore. your money only buys you 1,730 square feet. To see the complete list, CLICK HERE.
I love dividends. There’s nothing I like more than receiving a fat dividend payout and seeing that cold hard cash get deposited into my bank account.
The problem is, not many penny stocks pay dividends. So when you find a true penny stock paying dividends, you want to look at it quickly. And that’s what today’s On The Radar Report is all about.
Here’s a stock for you to take a closer look at….
Industry Residential REIT
Recent Price $7.49
Market Cap $362 m
Shares Outstanding 49.2 m
Average Volume 856,907
Dividend Yield 19.4%
ARMOUR Residential (NYSE: ARR) is a Maryland based REIT investing in residential mortgage backed securities. Their portfolios include adjustable-rate (5%), hybrid adjustable-rate (58.5%), and fixed rate mortgage-backed securities (36.5%).
All of their securities are issued or guaranteed by Fannie Mae, Freddie Mac, and others. Their portfolio’s worth about $4.7 billion as of June.
This REIT takes investors money, leverages it up, then buys mortgage backed securities. They capture the difference between their borrowing costs, and the yield on the debt.
Here’s another advantage… If you hate taxes then you’re going to love REITs. Because they are designated a REIT, they can pass along earnings directly to you… without paying corporate taxes on the money.
The catch is they have to distribute 90% of their income to investors.
All that means is that your dividends get fatter! Now, let’s look at the numbers…
Revenue in the first quarter jumped, reaching $13.7 million of interest income. Now, it’s a great number, but quarter over quarter, comparisons aren’t significant because the company raised capital, and has been increasing their asset base.
ARMOUR management has been aggressively raising capital. The most recent raise was for almost $118 million in cash. These funds are being deployed into new assets paying out high yields.
Ultimately, it means big cash flow for the company, and big earnings. Eventually those earnings make their way into the shareholder hands as dividends.
Speaking of dividends, the board of directors recently set their monthly dividend rate at $0.12 per share… through the third quarter. That means, if you’re a holder of the stock by July 15, and keep holding for the next three months, you’ll be guaranteed a payout of at least $0.36 for the quarter.
KEY METRICS ANALYSIS
Trailing P/E 5.9
Price / Sales 20.8
Return on Assets 1.1%
Insider ownership 2.9%
Short Ratio 0.6x
Current Ratio 0.03x
Total Debt To Equity NA
As we mentioned above, on June 14, 2011 ARMOUR put out a press release announcing their dividends schedule. Their Q3 2011 monthly rate is $.12 a share. The holder of record date is the 15th of each month in Q3. So there’s still ample time to get in on this while the getting’s good.
Scott J. Ulm – Co-CEO, Vice Chairman, CIO
Jeffrey J. Zimmer – Co-CEO, Vice Chairman, CFO
After bottoming out in mid 2010, ARR has been a steady climber. The stock recently retreated to the 50-day moving average, and is now bouncing higher. And we continue to trade well above the 200-day moving average.
ARR’s 52-week low was $6.10 and the 52-week high was $8.33. Right now the stock is trading at $7.49. The 50-day moving average is near $7.43 a share and the 200-day moving average is at $6.94. The company has a market cap of $362 million and 49.3 million shares outstanding.
As I write, it’s a balmy 115 degrees. Hot enough it seems to fry an egg on the sidewalk. While the sear of the sun can be draining… to one industry the heat of the sun does nothing but fill their wallets with money!
What industry am I talking about?
The solar energy industry of course! The powerful sun’s rays that can burn you to a crisp in a few minutes, also deliver a nice economic benefit. It’s a nearly free and endless supply of energy.
With the sun at the zenith, right now is a perfect time to examine solar stocks. So here’s a good one to put on your radar screen, Canadian Solar (CSIQ).
Industry Alternative Energy
Recent Price $11.34
Market Cap $485 m
Shares Outstanding 42.9 m
Average Volume 351,413
Dividend Yield “NA”
Canadian Solar (NASDAQ: CSIQ) is one of the world’s leading producers of solar modules. They provide ingots, wafers, solar cells, modules, and power systems. Pretty much anything solar related CSIQ has a hand in it.
They own eight manufacturing subsidiaries, operate in nine countries and have 9,000 employees.
The funny thing is… despite being called Canadian Solar, most of their operations are in China!
In their first quarter conference call management said Canadian Solar is a bigger player now than it was a year ago. They believe their supply chain agreements should reflect that.
Renegotiating supply contracts is just one measure management is taking to increase productivity. At the same time they are lowering their production costs. The company is attempting to expand their profits by growing sales and holding down costs.
Solar companies often measure their manufacturing capacity in megawatts (MW) and gigawatts (GW). CSIQ’s full year shipment for 2010 was 803 MW, and they expect their 2011 end of the year capacity to be 2.05 GW. That means there is room for Canadian solar to more than double sales!
They’ve also set an aggressive target to obtain 10% of the global market share in the next three to five years.
Lofty goals, but management seems confident in their growth potential and their ability to lower production costs.
Last quarter, their numbers were looking strong. Canadian Solar’s net revenue was up almost 32% to $443.4 million when compared to the prior quarter.
Gross Profit surged 55.8% to $65.3 million, with Gross Margin’s climbing to 14.7%. That’s up from 12.2% a year ago. Even net income rose to $5.9 million, with the company reporting an EPS of $0.13! A solid quarter all around.
Longer term, the company is heading in the right direction. EPS has grown from $0.24 in 2008 to a $0.60 profit in 2009, and then jumped to $1.16 at the end of 2010. This is a company that’s having its day in the sun!
Now, it’s not without some struggles.
Sales in Japan were temporarily halted following this year’s earthquake. They have now resumed, and management believes shipments will be back to normal levels soon. They expect growth in Japan’s sales to resume by the third quarter.
The company also seems pretty proud of their U.S. team for aggressive market development. Management said they expect to double sales to the U.S. by the end of 2011! .
KEY METRICS ANALYSIS
Trailing P/E 8.6x
Price / Sales 0.29x
Return on Assets 5.7%
Insider ownership N/A
Short Ratio 4.7x
Current Ratio 1.2x
Total Debt To Equity 156x
The last few months have been big for Canadian Solar. In May Canadian Solar and Suzhou GCL Photovoltaic Technology announced a new joint-venture. It entails building a plant with a 600 MW wafer capacity, with a future plan of expanding the plant to a 1.2 GW output.
Then on June 7, 2011 Canadian Solar announced a breakthrough on some of their ELPS solar cells. The cell efficiency is up 19.5% on monocrystalline, and 18% on polycrystalline cells.
CEO Shawn Qu said the ELPS cell technology is just one key ingredient in their strategy to lower production costs while simultaneously building a more efficient product.
Shawn (Xiaohua) Qu – CEO
Weiwen Chen – CFO
Gregory Spanoudakis – President, European Sales
Robert McDermott – Lead Independent Director
In terms of valuation CSIQ has a few interesting numbers. Their P/E ratio is a tiny 8.9x. Keep in mind that the average S&P 500 company trades for around 14x right now! That means the company is as much as 57% undervalued.
In addition they have a lot of growth prospects.
CSIQ’s 52-week low was $8.25 and the 52-week high was $17.63. Right now the stock is trading at $11.34. The 50-day moving average is near $9.61 a share and the 200-day moving average is at $11.91. The company has a market cap of $485 million and 42.9 million shares outstanding.
Discover the secrets every investor MUST know before buying ANY GOLD Investment. We’ll show you how to invest and outperform even GOLD’s phenomenal results. Get your FREE 12 page report NOW!
The world of online travel is fierce. This week we’re taking a look at one of the larger and more popular online travel companies. They’ve had some big court cases fall their way recently. As a result, many investors are looking more closely at the business… and the stock. Give them a close look yourself.
The next exciting company to put on your radar is Orbitz Worldwide (OWW).
Recent Price $2.37
Market Cap $243 m
Shares Outstanding 102.5 m
Average Volume 103,756
Dividend Yield “NA”
Last year Orbitz Worldwide (OWW) spent $217 million on marketing… so almost everybody in the world knows who they are! In case you don’t own a TV… Orbitz is an online travel company. Customers go online and book airline travel, hotel rooms, rental cars… anything they need for a business or vacation trip!
The company was founded in 2000 by a handful of major airlines looking to cash in on the growing demand for self-made travel plans.
The company owns a bunch of destination websites including cheaptickets.com, ebookers.com, and hotelclub.com. All are focused on the travel sector.
Now, the economy hasn’t been the best recently. Unemployment is high, and many people are struggling day to day. As a result, nobody has money for travel.
The travel industry is one of the hardest hit by the last recession.
In early May the company announced first quarter results. Gross bookings hit $2.9 billion up about 2% from the year earlier. Net revenue for OWW was $184 million down about 1% and the company showed a net loss of $10 million… that’s more than double the loss from a year earlier!
These numbers don’t look good.
Management knows it… that’s why they came right out and said “We’re not satisfied with our overall Q1 results…” CEO Barney Harford clearly has his work cut out for him.
Management expects next quarter revenue to be in a range of $194 to $200 million. I can’t wait to see what they do.
KEY METRICS ANALYSIS
Trailing P/E “NA”
Price / Sales 0.3
Return on Assets 2.5%
Insider ownership 1.0%
Short Ratio 7.3x
Current Ratio 0.5x
Total Debt To Equity 266.2x
OWW recently won a huge court case against American Airlines who tried to pull their flights off of Orbitz’s system. It was part of the reason sales numbers were down. The stock jumped higher on the news.
In other news, OWW recently scooped up the lucrative contract to service Eurostar, the high speed train that runs from London to Paris. They stole the business from their key competitor Expedia.
Barney Harford – CEO
Russel Hammer – CFO & Sr. Vice president
Samuel M Fulton – Sr. Vice President
Roger Liew – Sr. Vice President & CTO
Despite seeing an uptick on the American Airlines court case news, the stock is still in a downdraft. Orbitz is still trading below both the 200-day and well below the 50-day moving average.
OWW’s 52-week low was $2.06 and the 52-week high was $7.01. Right now the stock is trading at $2.37. The 50-day moving average is near $2.76 a share and the 200-day moving average is at $4.59. The company has a market cap of $243 million and 102.6 million shares outstanding.
Charts courtesy of stockcharts.com
This week we have an exciting write-up on a company in the biotechnology industry. Many novel little companies are working to solve some of the world’s largest health problems… and today’s company is no different.
The next exciting company to put on your radar is Sangamo Biosciences (NasdaqGM: SGMO)
Recent Price $5.85
Market Cap $306m
Shares Outstanding 52.3m
Average Volume 167,065
Dividend Yield N/A
Sangamo Biosciences (SGMO) is a biopharmaceutical company specializing in DNA-binding proteins. Essentially, the company is working to make the science fiction of gene modification a reality.
They’ve developed Zinc Finger DNA-binding proteins which can be used to force certain genes to turn on or off. Sangamo has a lot of Zinc Finger irons in the fire. They’re developing treatments for diabetic neuropathy, lateral sclerosis, spinal cord injuries, traumatic brain injuries, and even stroke.
The company even has a promising Zinc finger modified T-cell product for the treatment of HIV/AIDs.
Look, any way you slice it their technology is complex. However, as they develop new and radical treatments for some of the world’s largest health problems the rewards they could uncover are huge!
Researchers are excited about the potential of Zinc Finger DNA-binding protein treatments. Jay A. Levy, the head of the Laboratory for Tumor and AIDS Virus Research at the University of California said, “It’s a terrific way of looking for a long-term functional cure for the virus. This approach shows the most promise of any that I know of.”
SGMO is a biotech company, and they’re still in the process of proving their biotechnology really works. As a result they have very small revenue from collaboration agreements and research grants. It’s nothing to write home about.
The really big money will be made once one of their products is approved by the FDA!
The key to companies like this is comparing their Cash and Marketable Securities to any Debt that’s due. One quick look at the latest financial statements and we see the company has over $45 million in cash and securities, and no long term debt. Now a little more digging and we learn the company just completed a $50 million fundraising in April.
So their real cash balance is probably closer to $95 million – A fantastic position to be in!
KEY METRICS ANALYSIS
Trailing P/E N/A
Price / Sales 19.1
Return on Assets -28.9%
Insider ownership 5.7%
Short Ratio 18.3x
Current Ratio 14.2x
Total Debt To Equity N/A
In January the company finished up phase 2b of SB-509 testing. That’s the drug treating moderate or severe diabetic neuropathy. This study was undertaken to establish finalized dose and treatment schedules. Sangamo will announce results in the second half of 2011. Once results are in, the company can look towards potentially partnering with other drug companies.
On April 13, 2011, Sangamo finished an offering of 6.7 million shares raising over $50.2 million in cash.
Edward O Lanphier II – CEO & President
H Ward Wolff – CFO & Sr. Vice president
Dale Ando, M.D. – Vice President of Therapeutic Development and CMO
Philip Gregory, D. Phil – Vice President of Research and CSO
David Ichikawa – Senior Vice President of Business Development
Chart courtesy of stockcharts.com
SGMO stock has been in a downtrend for the last few weeks along with the overall market. Just this week the stock broke below the 200-day moving average and the 50 day moving average is in a downslope.
SGMO’s 52-week low was $2.81 and the 52-week high was $9.15. Right now the stock is trading at $5.95. The 50-day moving average is near $7.01 a share and the 200-day moving average is at $6.01. The company has a market cap of $306 million and 52.3 million shares outstanding.